当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Journal of Pharmaceutical Innovation杂志
Journal of Pharmaceutical Innovation
基本信息
期刊名称 Journal of Pharmaceutical Innovation
J PHARM INNOV
期刊ISSN 1872-5120
期刊官方网站 https://www.springer.com/12247
是否OA No
出版商 Springer New York
出版周期 4 issues per year
文章处理费 登录后查看
始发年份 2006
年文章数 104
最新影响因子 2.7(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 PHARMACOLOGY & PHARMACY 药学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.7 0.386 0.754
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
86/183 53%
Pharmacology, Toxicology and Pharmaceutics
Drug Discovery
96/157 39%
补充信息
自引率 7.80%
H-index 25
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1872-5120%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/jopi
收稿范围
The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI's goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories:

Materials science
Product design
Process design, optimization, automation and control
Facilities; Information management
Regulatory policy and strategy
Supply chain developments 
Education and professional development
Journal of Pharmaceutical Innovation publishes four issues a year.
收录体裁
投稿指南 https://link.springer.com/journal/12247/submission-guidelines
投稿模板
参考文献格式
编辑信息

EDITOR-IN-CHIEF

James K. Drennen, III, Duquesne University, Pittsburgh, PA, USA

CO-EDITOR

Stephen Scypinski, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA

ASSOCIATE EDITORS

Douglas Both, Bristol-Myers Squibb, New Brunswick, NJ, USA

Wilson Meng, Duquesne University, Pittsburgh, PA, USA

EDITORIAL ADVISORY BOARD

Ira Buckner, Duquesne University, Pittsburgh, PA, USA

Emanuel Diliberto, Campbell University, Builes Creek, NC, USA

Tom Fearn, University College London, London, UK

Mauricio Futran, Johnson & Johnson, New Brunswick, NJ, USA

Stefano Giovagnoli, University of Perugia, Perugia, Italy

Brijesh Dave, Amerigen Pharmaceuticals, Lyndhurst, NJ, USA

Robert Guttendorf, Aclairo Pharmaceutical Development Group, Vienna, VA, USA

Yukio Hiyama, National Institute of Health Sciences, Tokyo, Japan

Kristiina Jarvinen, University of Kuopio, Kuopio, Finland

Robert Lipper, Back Cove Pharma, LLC, Waldoboro, MA, USA

James Litster, University of Sheffield, Sheffield, UK

Robert Lodder, University of Kentucky, Lexington, KY, USA

Gary McGeorge, Bristol-Myers Squibb, New Brunswick, NJ, USA

Mike Morris, Health Products Regulatory Authority, Dublin, Ireland

June Mullaney Mader, GoForward LLC, Raleigh, NC, USA

Eric Munson, University of Kentucky, Lexington, KY, USA

Fernando Muzzio, Rutgers University, Piscataway, NJ, USA

Stuart Porter, Ashland Specialty Ingerdients, Wilmington, DE, USA

Rex Reklaitis, Purdue University, West Lafayette, IN, USA

Paul Sharratt, Institute for Chemical Engineering and Sciences (ICES), Jurong Island, Singapore

Steven Short, Merck & Co., Inc., Summit, NJ, USA

Nicholas Snow, Seton Hall University, South Orange, NJ, USA

Qiang Zheng, Peking University, Beijing, China

Sameer Talwar, GlaxoSmithKline, Collegeville, PA, USA


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug